Scarica l'app Stockscreener
120.52
0.21%
-0.25
Pre-mercato:
120.36
-0.16
-0.13%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Incyte Corp Borsa (INCY) Ultime notizie
Incyte Corporation (INCY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Incyte Corporation (INCY) has the Bigger Revenue Base, but Could Halozyme Therapeutics, Inc. (HALO) have the Better Economics? - Yahoo Finance
Incyte stock gains support as Q2 2026 sales surge and guidance rises - AD HOC NEWS
Incyte Sales Growth Drives Share Price Gains - FXEmpire
Insight Wealth Strategies LLC Acquires New Position in Incyte Corporation $INCY - MarketBeat
Q4 2025 Incyte Corp Earnings Call Transcript - GuruFocus
LTS:0J9P EV-to-OCF: 10.12 — 48% Below Median - GuruFocus
Incyte Corp (HAM:ICY) Stock Price, Trades & News - GuruFocus
Incyte Corporation (NASDAQ:INCY): What Could Drive Shares Next? - kalkinemedia.com
Incyte (INCY) Short Interest & Short Float | Updated Aug 2026 $INCY - MarketBeat
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Bank of America Corp DE Sells 87,913 Shares of Incyte Corporation $INCY - MarketBeat
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Finviz
Incyte Corp. stock outperforms competitors on strong trading day - MarketWatch
Incyte Corp (INCY) R&D head sells 10,640 shares in plan trade - Stock Titan
Incyte Corp (INCY) EVP sells 2,207 shares after option exercise - Stock Titan
Incyte Corp (ICY.HA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Incyte Corp. stock outperforms competitors despite losses on the day - MarketWatch
Incyte (NASDAQ:INCY) EVP Sells $5,005,254.54 in Stock - MarketBeat
Incyte Corp (INCY) R&D head sells 15,888 shares, retains 215,444 - Stock Titan
Incyte Corp (INCY) EVP sells 47,954 shares after exercising options - Stock Titan
Quantinno Capital Management LP Raises Position in Incyte Corporation $INCY - MarketBeat
The Manufacturers Life Insurance Company Sells 30,324 Shares of Incyte Corporation $INCY - MarketBeat
Amundi Purchases 229,783 Shares of Incyte Corporation $INCY - MarketBeat
Incyte (INCY) Won EU Approval For Opzelura, Has The Market Already Priced It In? - Yahoo Finance
Incyte (INCY) Wins EU Approval For Opzelura In Adult Moderate Atopic Dermatitis - Yahoo Finance
Incyte Corp. stock underperforms Friday when compared to competitors - MarketWatch
Incyte Corporation (INCY) Stock Forecasts - Yahoo Finance
Incyte Corporation $INCY Shares Acquired by Edgestream Partners L.P. - MarketBeat
Incyte Earnings: Opzelura Settlement and Latarcibart Improve Outlook Ahead of Jakafi Patent Loss - Morningstar
No-Moat Incyte Faces Jakafi Patent Cliff as Focus Remains on Opzelura and Expanding Portfolio - Morningstar
Incyte Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Incyte Shares Retreat After Best Day In A Year Despite Opzelura EU Nod - Stocktwits
Incyte lifts annual revenue forecast after settlement with CMS - pharma.economictimes.indiatimes.com
Incyte Corporation (INCY) Q2 2026 Earnings Call Transcript - AlphaStreet
Incyte stock jumps after Q2 beat and sharply higher 2026 sales outlook - Quiver Quantitative
A Noteworthy Decision By Lee Heeson As Acquires $130K In Incyte Stock Options - Benzinga
James Michael Morrissey Expands Holdings With $54K Incyte Stock Options Acquisition - Benzinga
Incyte Q2 Earnings Call Highlights - Yahoo Finance
INCY Looks 18.3% Overvalued on GF Value™ as Growth Momentum Rema - GuruFocus
Earnings call transcript: Incyte Q2 2026 beats forecasts, lifts guidance - Investing.com
Incyte Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Incyte Q2 Results: Adj. EPS $3.09 Beats Estimate, Sales Rise 37% - scanx.trade
INCY Looks 18.4% Overvalued on GF Value™ as of July 28, 2026 - GuruFocus
Incyte (INCY) Q2 Earnings and Revenues Top Estimates - Yahoo Finance Australia
INCY Looks 18.4% Overvalued on GF Value™ - GuruFocus
INCY Looks 18.4% Overvalued on GF Value™ as Growth Outlook Stren - GuruFocus
Is Incyte Corp (INCY) Worth the Current Valuation After Q2 Earni - GuruFocus
Incyte beats Q2 estimates but stock dips slightly on lowered guidance By Investing.com - Investing.com South Africa
Incyte (NASDAQ:INCY) Posts Better-Than-Expected Sales In Q2 CY2026 But Full-Year Sales Guidance Misses Expectations Significantly - Yahoo Finance
Incyte earnings beat by $1.10, revenue topped estimates - Investing.com
Incyte: Q2 Earnings Snapshot - 10TV
Incyte Revenue Rises 38 Percent to $1.67 Billion in Q2 - Quiver Quantitative
Incyte posts Q2 2026 revenue $1.67B, net income $586M; raises 2026 net sales outlook - TradingView
Incyte (NASDAQ: INCY) lifts 2026 sales outlook after strong Q2 results - Stock Titan
INCY|Incyte Corp|Price:118.880|Chg%:+1.210 - TradingKey
Form 4 Incyte Corporation For: 27 July By Investing.com - Investing.com South Africa
Incyte EVP Michael Morrissey Awarded Stock Options and Performance Shares in Equity Compensation Plan - Kalkine Media
Incyte Grants Heeson Lee Stock Options and Performance Shares Worth Notable Equity Compensation - Kalkine Media
Incyte (NASDAQ: INCY) awards EVP stock options, 8,999 performance shares - Stock Titan
Incyte Corp (INCY) awards options and performance shares to EVP - Stock Titan
INCY Looks 18.8% Overvalued on GF Value™ Heading into Q2 Earnings - GuruFocus
Incyte Corp (INCY) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Incyte Corp (INCY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
0.03%
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):